Viking Therapeutics, INC. (VKTX) — DEF 14A Filings
All DEF 14A filings from Viking Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Viking Therapeutics DEF 14A: Executive Compensation Details
— Apr 8, 2025 Risk: low
Viking Therapeutics, Inc. filed a DEF 14A on April 8, 2025, detailing executive compensation and equity awards for the fiscal years ending December 31, 2021, 20 -
Viking Therapeutics Files DEF 14A with SEC
— Apr 5, 2024 Risk: low
Viking Therapeutics, Inc. (VKTX) filed a Proxy Statement (DEF 14A) with the SEC on April 5, 2024. Viking Therapeutics, Inc. filed a DEF 14A form with the SEC on
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX